Start Over

PDGFBB promotes PDGFRα-positive cell migration into artificial bone in vivo.

Authors :: Yoshida S
Iwasaki R
Kawana H
Miyauchi Y
Hoshi H
Miyamoto H
Mori T
Kanagawa H
Katsuyama E
Fujie A
Hao W
Kobayashi T
Sato Y
Miyamoto K
Morioka H
Matsumoto M
Chiba K
Toyama Y
Nakagawa T
Miyamoto T
Source :: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2012 May 18; Vol. 421 (4), pp. 785-9. Date of Electronic Publication: 2012 Apr 23.
Publication Year :: 2012
Abstract: Bone defects caused by traumatic bone loss or tumor dissection are now treated with auto- or allo-bone graft, and also occasionally by artificial bone transplantation, particularly in the case of large bone defects. However, artificial bones often exhibit poor affinity to host bones followed by bony union failure. Thus therapies combining artificial bones with growth factors have been sought. Here we report that platelet derived growth factor bb (PDGFBB) promotes a significant increase in migration of PDGF receptor α (PDGFRα)-positive mesenchymal stem cells/pre-osteoblastic cells into artificial bone in vivo. Growth factors such as transforming growth factor beta (TGFβ) and hepatocyte growth factor (HGF) reportedly inhibit osteoblast differentiation; however, PDGFBB did not exhibit such inhibitory effects and in fact stimulated osteoblast differentiation in vitro, suggesting that combining artificial bones with PDGFBB treatment could promote host cell migration into artificial bones without inhibiting osteoblastogenesis.<br /> (Copyright © 2012 Elsevier Inc. All rights reserved.)